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Reduced male fertility is a complex disease with multifactorial 
aetiologies, in which genetic and epigenetic factors contrib-
ute to disease complexity (Krausz & Giachini, 2007). It has been 
shown that many genes are participating in the control of the 
spermatogenesis process, but the biological function of the major-
ity of these genes in the control of the spermatogenesis process 
is still unclear (Gianotten, Lombardi, Zwinderman, Lilford, & Veen, 
2004). However, the expression of these genes may be regulated 
by many biological factors, including microRNAs (miRNAs). Over 
the past decade, miRNAs have emerged as key post-transcriptional 
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Abstract
MicroRNAs (miRNAs) have recently received a significant amount of attention due to 
their remarkable influence on post-transcriptional gene regulation. In this study, we 
aim to provide a catalogue of miRNAs present in spermatozoa, seminal plasma and 
testicular tissue. Expression profiles of miRNA in spermatozoa and seminal plasma of 
16 proven fertile men and testicular tissue of eight men with morphologically and/
or histologically confirmed obstructive azoospermia were determined by microarray 
and RT-qPCR in combination with bioinformatics analyses. A total of 123, 156 and 
133 miRNAs were consistently detected in spermatozoa, seminal plasma and testicu-
lar tissue respectively. Sixty-four miRNAs were shared across all sample types. Based 
on miRNAs expression level present in each group, correlation analysis showed mod-
erate-to-strong correlations within the spermatozoa and seminal plasma samples and 
a wider range of correlations within the testicular tissue samples. The target genes 
of known miRNAs appeared to be involved in a wide range of biological processes 
related to reproduction, development and differentiation of germ cells. Our results 
suggest that there is a certain similarity between spermatozoa and seminal plasma 
for the relative miRNA expression changes with respect to testicular tissue and pro-
vide an overview of the miRNAs present in each sample type.
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regulators of gene expression (Ha & Kim, 2014). To date, accumu-
lating studies have indicated that miRNAs are participating in the 
control of many, if not all, biological and pathological processes 
(Gurtan & Sharp, 2013). In mammalian spermatogenesis, evidence 
indicates that even a slight alteration in miRNA expression activi-
ties can be detrimental to germ cell function, ultimately leading to 
impaired spermatogenesis and compromised fertility (Chang et al., 
2012; Hayashi et al., 2008; Maatouk, Loveland, McManus, Moore, 
& Harfe, 2008). Altered expression of miRNAs in men with reduced 
fertility has been investigated (Abu-Halima et al., 2019, 2013, 
2016; Abu-Halima, Backes, et al., 2014; Abu-Halima, Hammadeh, 
et al., 2014). Specifically, differentially expressed miRNAs were 
reported in spermatozoa of infertile men with normozoospermic 
versus. subfertile men with asthenozoospermic and oligoastheno-
zoospermic (Abu-Halima et al., 2013), in testes of men with normal 
versus. impaired spermatogenesis (in Sertoli cell only, mixed atro-
phy and germ cell arrest) (Abu-Halima, Backes, et al., 2014) and 
in extracellular microvesicles obtained from seminal plasma from 
normozoospermic versus oligoasthenozoospermic men (Abu-
Halima et al., 2016). Although several miRNAs have been found 
altered in certain spermatogenic impairments, the exact cellular 
function and biological mechanism of these miRNAs have been re-
vealed for a very limited number of miRNAs. With this study, by 
using miRNA microarrays along with the bioinformatics analysis, 
we aim to provide a catalogue of miRNAs present in spermatozoa 
and seminal plasma of proven fertile men and testicular tissue of 
men with obstructive azoospermia.
2  | METHODS
2.1 | Study population
Following Institutional Ethics Committee of Saarland University 
(Nr. Ha195/11) approval, eight semen samples were obtained from 
men aged between 26 and 34 years (29 ± 3.12, Mean ± SD) with 
proven fertility, that is men with normal semen parameters and 
parenthood after the investigation (Table S1). Semen samples were 
provided after at least three days of sexual abstinence, and semen 
parameters, including volume, pH, viscosity, sperm count (106/ml), 
motility (motile %) and morphology (%) were performed based on the 
World Health Organization, 2010, (WHO, 2010) guidelines. Using 
Puresperm 45%–90% discontinuous density gradients, 1 ml of the 
semen sample was placed on the upper layer before centrifugation 
at 500 g for 15 min at room temperature (RT). After centrifugation, 
the upper seminal plasma layer was aspirated and transferred to a 
new sterile 1.5-mL Eppendorf tube for total RNA including miRNAs 
purification. In addition, purified RNA from spermatozoa samples 
(n = 8) were obtained from our previous study (Abu-Halima et al., 
2013). These samples were collected from proven fertile men aged 
between 24 and 34 years (34 ± 5.6, Mean ± SD) (Table S1). Purified 
RNA from testicular samples (n = 8) were obtained from our previous 
study (Abu-Halima, Backes, et al., 2014; Abu-Halima, Hammadeh, et 
al., 2014). These samples were obtained from men aged between 
24 and 30 (27 ± 2.1, Mean ± SD), with normal testicular volume, no 
evidence of inflammatory granuloma or malignancy, and the testis 
exhibited nearly normal spermatogenesis process with many mature 
sperms noted and populated by normal Sertoli cells and Leydig cells 
number.
2.2 | Purification and quality assessment
Purification of miRNA from seminal plasma was performed as previ-
ously described (Wu et al., 2012), with a slight modification. Briefly, 
200 µl of the seminal plasma was used for total RNA purification. 
The total RNA was isolated by mixing the seminal plasma with an 
equal volume of TRIzol reagent (Thermo Fisher Scientific), and the 
procedure was completed according to the manufacturer's proto-
col. Three steps of phenol/chloroform purification were added to 
get rid of proteins. The quantity and purity were tested using the 
NanoDrop ND-2000 spectrophotometer (Thermo Fisher Scientific). 
The integrity of the purified RNAs was assessed using Agilent 2100 
Bioanalyzer (Agilent Technologies). DNase treatment was carried 
out to remove the gDNA carry-over as described previously (Abu-
Halima et al., 2016).
2.3 | Analysis of miRNAs by microarray
The miRNA expression profile in the spermatozoa and testicular 
tissue samples was obtained from our previously generated and 
published raw data using SurePrint™ 8X60K Human v16 miRNA 
platform (Agilent Technologies) (Abu-Halima, Backes, et al., 2014; 
Abu-Halima et al., 2013). As for seminal plasma samples, miRNA 
profiling analysis was carried out on the purified RNA fraction 
from eight seminal plasma samples using the SurePrint™ 8X60K 
Human v16 miRNA platform (Agilent Technologies). These plat-
forms contain probes for the detection of 1,205 human miRNAs. 
One hundred nanograms (ng) of the purified RNA were labelled 
and subsequently hybridized to the miRNA microarray chip as pre-
viously described (Abu-Halima, Backes, et al., 2014; Abu-Halima 
et al., 2013).
2.4 | Reverse Transcription and Quantitative Real-
Time PCR (RT-qPCR) of miRNA
The expression level of certain miRNAs in each sample was determined 
using the miScript PCR System (Qiagen). One hundred nanograms (ng) 
purified RNA from each sample, that is spermatozoa (Abu-Halima et al., 
2013), testicular tissue (Abu-Halima, Backes, et al., 2014) and seminal 
plasma, were reverse transcribed using the miScript RT II kit (Qiagen). 
The cDNA was then diluted 1:10, and 1 µl of cDNA was mixed with 
10 µl 2X QuantiTect SYBR Green, 2 µl 10X Universal Primer Assay, 
2 µl 10X Specific Primer Assay and H2O in a total volume of 20 µl.
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The miRNA primer assays were selected based on their abundance 
level changes in men with subfertility compared to men with proven 
fertility and based on their known associations with spermatogenesis. 
In detail, 11 miRNAs were validated in spermatozoa (miR-10a-5p, miR-
122-5p, miR-34b-3p, miR-16-5p, miR-1299, miR-513a-5p, miR-34b-5p, 
miR-30d-5p, miR-125b-5p, miR-10b-5p and miR-125a-3p), 5 miRNAs 
in seminal plasma (miR-141-3p, miR-26b-5p, Let-7b-5p, miR-125a-3p 
and miR-99a) and 8 miRNAs in testicular tissue (miR-107, miR-145-5p, 
miR-20a-5p, miR-449a, miR-513b-5p, miR-125b-5p, miR-99a and Let-
7d-5p). All experiments were carried out on the QIAgility™ automated 
PCR setup robot (Qiagen) and StepOnePlus™ Real-Time PCR cycler 
(Applied Biosystems).
2.5 | Bioinformatics analysis
Since the samples came from different sources, we cannot directly 
compare the expression level of miRNAs across the sample groups. 
Therefore, we focused on relative differences between the groups. 
Arrays data were quantile normalised by using the preprocessCore 
package of the R software (www.R-proje ct.org). The resulting val-
ues were shifted by the absolute value of the minimal expression 
level (determined over the whole data set) and additionally by 0.1 
to ensure that all values are positive. Finally, a log2 transformation 
of the data was performed (Figure 1a). Additionally, a detection 
matrix was generated where a miRNA is considered to be detected 
in a sample of its total probe signal is bigger than 3*probe error. 
Probe error is the robust average of all the processed green signal 
errors for each replicated probe multiplied by the total number of 
probe replicates: the effective feature size fraction, the nominal 
spot area and the weight. Therefore, it is an estimate of the probe 
signal error provided by the Feature Extraction software from 
Agilent. To classify a miRNA as absent, present or undetermined, 
we defined two thresholds for each sample group computed from 
the processed expression levels of miRNAs detected in 0% and 
100% of all samples in the corresponding group. In our analysis, 
we concentrated on miRNAs classified as present with respect to 
the three sample groups. The present identified miRNA list was 
then converted from v16 to v21 according to the updated miRBase 
database (Release 22.1). The miRNAs which were not matched/
identified were subsequently removed from the database. Then, 
we determined the within-group sample correlation computing 
Spearman's correlation coefficient based on miRNAs present in 
the corresponding group. Furthermore, pairwise miRNA correla-
tions with the corresponding p-values were calculated for present 
miRNAs for each group separately. P-values were corrected using 
the Bonferroni correction. Finally, we performed a quantile rank 
analysis (Smalheiser et al., 2012) applied to all miRNAs in our data 
set to identify miRNAs whose rank changed significantly between 
two sample groups. The 2-ΔCq relative quantitative procedure 
(Livak & Schmittgen, 2001) was used to detect the expression 
changes of single miRNAs. The small nuclear RNA (snRNA) RNU6B 
was chosen as a reference endogenous for normalisation.
3  | RESULTS
3.1 | Subjects characteristics
In total, we compared 24 miRNA expression profiles, including eight 
profiles from the seminal plasma of fertile men, that is men with 
normal semen parameters and proven fertility. Eight miRNA expres-
sion profiles from spermatozoa of men with proven fertility were in-
cluded from our previous study (Abu-Halima et al., 2013). We had, 
however, problems in collecting testicular tissues from men with 
proven fertility. Therefore, eight miRNA expression profiles from 
testicular tissues of men with morphologically and/or histologically 
confirmed obstructive azoospermia were included as control tissue 
from our previous study (Abu-Halima, Backes, et al., 2014).
3.2 | Present and absent miRNAs
The data set was quantile normalised using the R-package pre-
processCore (R Development Core Team 2010) (Figure 1a). To 
classify miRNAs as present or absent, we defined two expres-
sion level thresholds (one for absence and one for presence) for 
each sample group. These thresholds were computed as follows: 
Assuming that not detected miRNAs demonstrate lower expres-
sion levels and detected miRNAs tend to have a high expression 
level, we estimated the density distribution of miRNA expression 
values for miRNAs with 0% and 100% detection rate in the con-
sidered sample group using R-package sm (Shah, Leidinger, Blin, & 
Meese, 2010). The 1 percentile of the 100% detection rate density 
distribution and the 99 percentile of the 0% detection rate density 
distribution were set as the thresholds for the absent and present 
miRNAs respectively (Figure 1b): We defined a miRNA as present 
or absent under the following conditions: a miRNA is considered 
as present if its expression value is above the upper threshold (99 
percentile) and absent if its expression value is below the lower 
threshold (1 percentile), and otherwise, the miRNA was defined 
as undetermined. Second, a miRNA is present/absent in a sample 
group if it is present or absent in all samples of the considered 
group, that is in spermatozoa, seminal plasma and testicular tissue. 
Out of 1,205 investigated miRNAs, 697, 729 and 691 were not 
detected (absent) and 126, 161 and 137 miRNAs were detected 
(present) in spermatozoa, seminal plasma and testicular tissue re-
spectively (Tables S2 and S3). Using the miRCarta web-service tool 
(Backes et al., 2018), we converted the present miRNAs from v16 
to v21 according to the updated miRBase database (Release 22.1, 
http://www.mirba se.org/). Three miRNAs (miR-1274b, miR-720 
and miR-1280), five miRNAs (miR-1274b, miR-3676, miR-1274a, 
miR-720 and miR-1280) and four miRNAs (miR-1274b, miR-1274a, 
miR-720 and miR-1280) were not detected in the updated ver-
sion of miRBase v22.1 and have subsequently been removed 
from the present miRNA list of each group, that is spermatozoa, 
seminal plasma and testicular tissue respectively. A detailed list 
of miRNAs that cannot be found in the destination annotation (in 
4 of 12  |     ABU-HALIMA et AL.
a more recent miRBase 22.1 version) is reported in bold in Table 
S3. Therefore, in total, 123, 156 and 133 miRNAs were present 
in spermatozoa, seminal plasma and testicular tissue, respectively, 
according to miRBase v22.1. The Venn diagrams in Figure 2a,b 
show the overlap of present miRNAs sets between the three 
sample groups. As shown in Table 1, 18 miRNAs present only in 
spermatozoa, and 50 miRNAs in seminal plasma and 38 miRNAs in 
testicular tissue samples were identified.
F I G U R E  1   (a) Box plots of shifted (by 
|minimal value| and 0.1) raw expression 
levels per sample on log2-scale and (b) 
estimated density distributions based on 
processed expression levels of miRNAs 
with a detection rate of 0% (red), 50% 
(green) and 100% (blue) in the sample 
groups. The two thresholds are visualised 
by two dashed vertical lines
F I G U R E  2   Venn diagram of (a) absent 
miRNAs and (b) present miRNAs
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TA B L E  1   The present/detected miRNAs in spermatozoa, seminal plasma and testicular tissue
miRNAs present in 'only’ spermatozoa miRNAs present in 'only' seminal plasma miRNAs present in 'only' testicular tissue
miRBase accession MicroRNA miRBase accession MicroRNA miRBase accession MicroRNA
MIMAT0000686 hsa-miR-34c-5p MIMAT0004812 hsa-miR-548d-5p MIMAT0009447 hsa-miR-1972
MIMAT0015089 hsa-miR-3202 MIMAT0004806 hsa-miR-548c-5p MIMAT0002881 hsa-miR-509-3p
MIMAT0015073 hsa-miR-3190-5p MIMAT0000707 hsa-miR-363-3p MIMAT0000080 hsa-miR-24-3p
MIMAT0018110 hsa-miR-3682-3p MIMAT0017992 hsa-miR-3614-5p MIMAT0001541 hsa-miR-449a
MIMAT0000081 hsa-miR-25-3p MIMAT0005826 hsa-miR-1181 MIMAT0002819 hsa-miR-193b-3p
MIMAT0000421 hsa-miR-122-5p MIMAT0016921 hsa-miR-4290 MIMAT0000084 hsa-miR-27a-3p
MIMAT0005893 hsa-miR-1305 MIMAT0002843 hsa-miR-520b MIMAT0001341 hsa-miR-424-5p
MIMAT0004676 hsa-miR-34b-3p MIMAT0016862 hsa-miR-4310 MIMAT0000419 hsa-miR-27b-3p
MIMAT0015030 hsa-miR-3156-5p MIMAT0016864 hsa-miR-4312 MIMAT0000443 hsa-miR-125a-5p
MIMAT0015028 hsa-miR-3154 MIMAT0000420 hsa-miR-30b-5p MIMAT0000461 hsa-miR-195-5p
MIMAT0016858 hsa-miR-4306 MIMAT0002174 hsa-miR-484 MIMAT0000418 hsa-miR-23b-3p
MIMAT0014990 hsa-miR-3127-5p MIMAT0004947 hsa-miR-885-5p MIMAT0002883 hsa-miR-514a-3p
MIMAT0014988 hsa-miR-3125 MIMAT0000753 hsa-miR-342-3p MIMAT0000231 hsa-miR-199a-5p
MIMAT0003263 hsa-miR-595 MIMAT0000243 hsa-miR-148a-3p MIMAT0018071 hsa-miR-3651
MIMAT0005887 hsa-miR-1299 MIMAT0003298 hsa-miR-629-3p MIMAT0000425 hsa-miR-130a-3p
MIMAT0000253 hsa-miR-10a-5p MIMAT0000318 hsa-miR-200b-3p MIMAT0002820 hsa-miR-497-5p
MIMAT0018361 hsa-miR-3945 MIMAT0000617 hsa-miR-200c-3p MIMAT0004975 hsa-miR-509–3-5p
MIMAT0000068 hsa-miR-15a-5p MIMAT0018105 hsa-miR-3679-3p MIMAT0000078 hsa-miR-23a-3p
MIMAT0004950 hsa-miR-877-3p MIMAT0000075 hsa-miR-20a-5p
MIMAT0001343 hsa-miR-425-3p MIMAT0002811 hsa-miR-202-3p
MIMAT0018099 hsa-miR-3675-3p MIMAT0000265 hsa-miR-204-5p
MIMAT0003270 hsa-miR-602 MIMAT0005789 hsa-miR-513c-5p
MIMAT0005949 hsa-miR-664a-3p MIMAT0005788 hsa-miR-513b-5p
MIMAT0004811 hsa-miR-33b-3p MIMAT0003326 hsa-miR-663a
MIMAT0018000 hsa-miR-23c MIMAT0004605 hsa-miR-129–2-3p
MIMAT0004482 hsa-let-7b-3p MIMAT0000104 hsa-miR-107
MIMAT0004800 hsa-miR-550a-5p MIMAT0000232 hsa-miR-199a-3p
MIMAT0004748 hsa-miR-423-5p MIMAT0000065 hsa-let-7d-5p
MIMAT0018001 hsa-miR-3620-3p MIMAT0000066 hsa-let-7e-5p
MIMAT0002176 hsa-miR-485-3p MIMAT0000092 hsa-miR-92a-3p
MIMAT0007401 hsa-miR-1539 MIMAT0004697 hsa-miR-151a-5p
MIMAT0000100 hsa-miR-29b-3p MIMAT0000437 hsa-miR-145-5p
MIMAT0004976 hsa-miR-933 MIMAT0000760 hsa-miR-331-3p
MIMAT0004808 hsa-miR-625-3p MIMAT0000271 hsa-miR-214-3p
MIMAT0007348 hsa-miR-1470 MIMAT0002878 hsa-miR-506-3p
MIMAT0016906 hsa-miR-4274 MIMAT0000082 hsa-miR-26a-5p
MIMAT0000432 hsa-miR-141-3p MIMAT0000101 hsa-miR-103a-3p
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3.3 | Correlation analysis results
To determine the degree of correlation across individual samples 
within each group, we computed the pairwise sample correlations 
(Spearman's correlation coefficient) based on miRNAs expression 
level present in the considered sample group (Table S4). Figure 3a 
shows a histogram of the resulting correlation values for each 
sample group separately. We found the strongest correlation be-
tween the spermatozoa samples ranging from 0.633 to 0.964. The 
second strongest correlation was found among the seminal plasma 
samples with correlation values between 0.544 and 0.947. In con-
trast, the correlation values in the testicular tissue group ranged 
from 0.02 to 0.913 with the lowest values found between samples 
1, 4, 5, 6, 7 and 8 (Figure 3b–d). These results can be explained by 
the presence of various cell types in the testis (i.e. germ and so-
matic cells) causing increased heterogeneity. The high correlation 
between the miRNA expression values of spermatozoa and semi-
nal plasma likely reflects the homogeneity of the samples within 
these groups.
3.4 | Quantile rank analysis of miRNA 
expression data
To determine miRNAs whose expression was different between two 
sample groups without a direct comparison of the expression levels, 
we performed quantile rank analysis (Smalheiser et al., 2012). For each 
miRNA, we computed its mean expression for each sample group sep-
arately. In each group, the miRNAs were sorted by their mean group 
expression in a decreasing order to determine their ranks. Next, we 
computed for each pair of groups the rank differences of the miRNAs. 
These values were approximately normally distributed with mean = 0 
for all three group pairs and standard deviation of 195.5, 211.5 and 
224.8 for spermatozoa/seminal plasma, spermatozoa/testicular tissue 
and seminal plasma/testicular tissue respectively (Figure 3e). Finally, 
the probability to achieve a more extreme rank change by chance was 
determined for all rank differences. Table S5 contains the 18 miRNAs 
with at least one significant rank difference comparing two groups. 
These findings suggest that there is a certain similarity between sper-
matozoa and seminal plasma regarding the relative miRNA expression 
changes as compared to testicular tissue. However, there are also rank 
differences between spermatozoa and seminal plasma for six other 
miRNAs, which seem to be specific for these two groups.
3.5 | Most expressed and most stable miRNAs
We determined the most expressed and stable miRNAs. The most 
expressed miRNAs were defined by a high mean expression value 
and the most stable miRNA by a low standard deviation. This analy-
sis was done for each tissue/cell type separately. Among the most 
expressed miRNAs, three miRNAs namely miR-4281, miR-2861 and 
miR-638 were shared across all sample groups and 7 miRNAs were 
shared between spermatozoa and seminal plasma as indicated in 
Table 2. As for the most stable miRNAs, we did not find a stable 
miRNA that was shared among the three tested groups (Table 2).
3.6 | miRNA target genes prediction
The Gene Ontology (GO) was considered to elucidate the biologi-
cal function of the identified miRNAs for each sample group sepa-
rately. To this end, we extracted miRNA targets using the miRWalk 
2.0 (Dweep & Gretz, 2015) and we used the list of unique genes for 
the enrichment analysis. The most enriched GO terms for the sper-
matozoa, seminal plasma and testicular tissue are listed in Table S6.
3.7 | Validation of microarray results by RT-qPCR
Of the miRNAs present in each group, we validated 11 miRNAs from 
spermatozoa, 5 miRNAs from seminal plasma and 8 miRNAs from tes-
ticular tissue by RT-qPCR. These miRNAs were chosen based on their 
abundance level changes and based on their known associations with 
spermatogenesis. The selected miRNA expression level was largely con-
cordant with the microarray expression data as expected (Figure 4a–c).
4  | DISCUSSION
In this study, we investigated the miRNA expression profile in 
spermatozoa and seminal plasma of men with proven fertility and 
miRNAs present in 'only’ spermatozoa miRNAs present in 'only' seminal plasma miRNAs present in 'only' testicular tissue







TA B L E  1   (Continued)
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F I G U R E  3   (a) Histogram of within-group sample correlation based on present miRNAs for spermatozoa (green), seminal plasma 
(red) and testicular tissue (blue), (b) pairwise Spearman's correlation coefficient computed for samples in the group spermatozoa, (c) 
pairwise Spearman's correlation coefficient computed for samples in the group seminal plasma, (d) pairwise Spearman's correlation 
coefficient computed for samples in the group testicular tissue and (e) histogram of rank differences computed for each sample group pair 
(spermatozoa/seminal plasma, spermatozoa/testicular tissue and seminal plasma/ testicular tissue)
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testicular tissue of men with obstructive azoospermia. In total, 123, 
156 and 133 miRNAs were consistently detected in spermatozoa, 
seminal plasma and testicular tissue respectively. Out of the identi-
fied miRNAs, 18, 50 and 38 miRNAs were only found in spermatozoa, 
seminal plasma and testicular tissue respectively. These miRNAs are 
specific for each sample type. However, the origin of the identified 
miRNA still needs to be further discussed for each sample type spe-
cifically. Five miRNAs namely miR-1274a, miR-1274b, miR-720, miR-
1280 and miR-3676 were reported as ‘dead entries’ and have been 
removed from present miRNA list. The putative mature sequences 
of these five miRNAs were fragments of transfer ribonucleic acids 
(tRNAs) (Schopman, Heynen, Haasnoot, & Berkhout, 2010; Vaz et 
al., 2010).
Among the miRNAs that were detected in spermatozoa samples 
from subfertile men but not infertile men (Abu-Halima et al., 2013), 
miR-122 has been described to participate in the post-transcriptional 
down-regulation of the transition protein 2 (TNP2) during spermato-
genesis (Krawetz et al., 2011; Salas-Huetos et al., 2014; Yu, Raabe, & 
Hecht, 2005). Lower abundance level of miR-122 has been observed 
in seminal plasma and spermatozoa of men with nonobstructive azo-
ospermia (NOA) and of subfertile men. MiR-122 might also have di-
agnostic value to confirm male infertility (Abu-Halima, Hammadeh, 
et al., 2014; Wang et al., 2011). MiR-19b and has-miR-34b were highly 
expressed and stably detected in the spermatozoa of proven fertile 
men (Salas-Huetos et al., 2014). MiR-34b was over-expressed in the 
spermatozoa collected from mature CD-1 mice (Garcia-Lopez et al., 
2015). In addition, lower abundance levels of miR-34b and miR-15a 
were observed in subfertile compared to fertile men (Abu-Halima, 
Hammadeh, et al., 2014; Abu-Halima et al., 2013). MiR-19b abun-
dance levels were higher in the seminal plasma of idiopathic infertile 
men with NOA compared to fertile controls (Wu et al., 2012). Other 
miRNAs like miR-3202, miR-3190, miR-3137, miR-3682, miR-1305, 
miR-3156, miR-3127, miR-3125, miR-595, miR-1183, miR-1299 and 
miR-3945 have not been reported to be involved in any biological 
and/or cellular function associated with spermatogenesis or related 
processes. It remains to be seen whether the newly identified miR-
NAs are specific for germ cells and/or if their aberration is associated 
with impaired spermatogenesis.
Among the miRNAs detected in seminal plasma, five miR-
NAs (miR-629-3p, miR-200b-3p, miR-425-3p, miR-33b-3p and 
miR-141-3p) were previously described as being among the most 
stably expressed miRNAs in seminal plasma-derived exosomes 
(Barcelo, Mata, Bassas, & Larriba, 2018). MiR-141-3p was reported 
to be stable in seminal plasma (Wu et al., 2013). Six miRNAs (miR-
363-3p, miR-148a-3p, miR-200b-3p, miR-425-3p, miR-3675-3p 
and miR-26b-5p) were previously described as being abundantly 
expressed in human extracellular microvesicles isolated from 
seminal plasma of patients with oligoasthenozoospermia (Abu-
Halima et al., 2016). MiR-363-3p, miR-148a-3p, miR-200b-3p, 
miR-200c-3p, miR-425-3p, miR-1825, miR-33b-3p, miR-550a-5p, 
miR-625-3p, miR-1470, miR-141-3p and miR-26b-5p have been 
previously found to be abundant in the spermatozoa samples of 
TA B L E  2   Top-most expressed (highest mean) and stable (lowest standard deviation) miRNAs across the sample groups
Most expressed miRNAs
Spermatozoa Seminal plasma Testicular tissue
miRBase accession MicroRNA miRBase accession MicroRNA miRBase accession MicroRNA
MIMAT0016907 hsa-miR-4281 MIMAT0016907 hsa-miR-4281 MIMAT0016907 hsa-miR-4281
MIMAT0003299 hsa-miR-630 MIMAT0005865 hsa-miR-1202 MIMAT0004795 hsa-miR-574-5p
MIMAT0013802 hsa-miR-2861 MIMAT0005572 hsa-miR-1225-5p MIMAT0003308 hsa-miR-638
MIMAT0003308 hsa-miR-638 MIMAT0005871 hsa-miR-1207-5p MIMAT0013802 hsa-miR-2861
MIMAT0005572 hsa-miR-1225-5p MIMAT0013802 hsa-miR-2861 MIMAT0000063 hsa-let-7b-5p
MIMAT0005793 hsa-miR-320c MIMAT0016900 hsa-miR-4270 MIMAT0016916 hsa-miR-4286
MIMAT0005871 hsa-miR-1207-5p MIMAT0003308 hsa-miR-638 MIMAT0002816 hsa-miR-494-3p
MIMAT0018087 hsa-miR-3665 MIMAT0005793 hsa-miR-320c MIMAT0018076 hsa-miR-3656
MIMAT0005865 hsa-miR-1202 MIMAT0018076 hsa-miR-3656
Most stable miRNAs
Spermatozoa Seminal plasma Testicular tissue
miRBase accession MicroRNA miRBase accession MicroRNA miRBase accession MicroRNA
MIMAT0004761 hsa-miR-483-5p MIMAT0016907 hsa-miR-4281 MIMAT0000762 hsa-miR-324-3p
MIMAT0018185 hsa-miR-3911 MIMAT0004982 hsa-miR-939-5p MIMAT0000510 hsa-miR-320a
MIMAT0015005 hsa-miR-3137 MIMAT0005922 hsa-miR-1268a MIMAT0002824 hsa-miR-498
MIMAT0005865 hsa-miR-1202 MIMAT0018104 hsa-miR-3679-5p MIMAT0005793 hsa-miR-320c
MIMAT0015036 hsa-miR-3162-5p MIMAT0018076 hsa-miR-3656 MIMAT0005788 hsa-miR-513b-5p
MIMAT0004610 hsa-miR-150-3p MIMAT0007892 hsa-miR-1915-3p
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men with spermatogenic impairments (Abu-Halima et al., 2013). 
MiR-1181 and miR-135a-3p were found in testicular tissue of men 
with different testicular impairments (Abu-Halima, Backes, et al., 
2014) suggesting that the miRNA profiles in seminal plasma are 
similar to the profiles in the spermatozoa and different to the pro-
files in the testicular tissue.
Semen sample purification is a mandatory procedure in the IVF 
laboratory and before running miRNA/mRNA expression analysis 
of spermatozoa and seminal plasma because semen samples are 
routinely contaminated with somatic cells such as leucocytes, mac-
rophages and epithelial cells of the genital tract. The problem of so-
matic transcript contamination in expression studies of spermatozoa 
has not been solved adequately to date and is a topic that needs 
further investigation (Jodar et al., 2015). The somatic transcript ex-
press miRNAs that might slightly bias the resulting miRNA expres-
sion profiles even after applying many purification methodologies 
(Abu-Halima et al., 2013).
As for the normal testicular tissue, several studies reported 
that testicular-expressed miRNA changes depending on the stage 
of spermatogenesis (Hayashi et al., 2008; Maatouk et al., 2008) 
and the presence of various cell types in the testis (i.e., germ and 
somatic cells) increase the heterogeneity of the testis. According 
to the studies, each of these cell populations has a specific miRNA 
profile and/or a stage-specific miRNA profile. In our study, how-
ever, the testicular tissue samples were taken from 8 different men 
diagnosed with OA and with morphologically and/or histologically 
normal spermatogenesis, and each of these testicular tissues might 
contain different stages of normal cell division and development. 
These findings have been supported by many studies suggesting 
that late meiotic and haploid germ cells are the main source of 
miRNA production during spermatogenesis (Bouhallier et al., 
2010; Guo, Su, Zhou, & Sha, 2009; Ro, Park, Sanders, McCarrey, 
& Yan, 2007). Among the identified miRNAs, nine miRNAs (miR-
509-3p, miR-27b-3p, miR-125a-5p, miR-514a-3p, miR-509-3-5p, 
let-7i-5p, miR-26a-5p, let-7g-5p and miR-100-5p) were recently 
found as most abundantly expressed in human normal testicular 
tissue (Tang et al., 2018). A cluster of six miRNAs namely miR-
509-3p, miR-509-5p, miR-514a-3p, miR-513b-5p, miR-513c-5p and 
F I G U R E  4   Real-time PCR validation of some selected miRNAs in the (a) spermatozoa, (b) testicular tissue and (c) seminal plasma of male 
with normal spermatogenesis as determined by RT-qPCR (p < .05). RNAU6B as an endogenous control for normalisation. Normalised 2−ΔCq 
values and mean ± standard deviation (STDV) were used to represent the differences in expression
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miR-506-3p have been reported to be exclusively expressed in the 
testicular tissues of men with carcinoma in situ (Abu-Halima et 
al., 2013; Novotny et al., 2012). Another conserved miRNA fam-
ily, miR-34, which is structurally similar to the miR-449 family, 
has previously been identified to be highly enriched in germ cells 
(Bouhallier et al., 2010; Niu et al., 2011). Additionally, miR-449a 
and miR-199a-3p were highly expressed in cryptorchid testicle 
tissues (TANG et al., 2018). The miR-23 family (miR-23a, miR-
23b and miR-23c) was highly deregulated in spermatozoa, sem-
inal plasma-derived exosomes and testicular tissue of subfertile 
men compared with fertile men (Abu-Halima et al., 2019, 2013, 
2016; Abu-Halima, Backes, et al., 2014). More recently, the miR-
23 family was found to be highly expressed in the spermatozoa 
and testicular tissue of patients with different spermatogenic and 
testicular impairments. The miR-23 family targets many spermato-
genesis-specific genes like PFKFB4, HMMR, SPATA6 and TEX15. 
These genes have been identified to be involved in the spermato-
genesis process of male infertility (Abu-Halima et al., 2019).
There is rather limited information on the cellular function of the 
expressed and stable miRNAs for the process of spermatogenesis. 
The Let-7 family, a highly conserved miRNA family in the testis that 
contributes significantly to the control of male germ cell lineage, is 
specifically deregulated in testicular cancer (Johnson et al., 2007; 
Jung, Gupta, Shin, Uhm, & Lee, 2010). In addition, Let-7 family was 
observed to be abundantly detected in testicular tissue, spermato-
zoa and embryonic spent culture media of IVF correlated with suc-
cessful pregnancy (Abu-Halima, Backes, et al., 2014; Abu-Halima et 
al., 2013, 2017).
The expression level of miR-574-5p is reported to be significantly 
higher in the semen sample of subfertile men as compared to con-
trols (Liu, Cheng, Gao, Wang, & Liu, 2012). The expression level of 
miR-574-5p is also reported to be lower in spermatozoa samples 
from oligoasthenozoospermic subfertile men as compared to those 
from normozoospermic fertile men (Abu-Halima et al., 2013). In men 
with Sertoli cell-only syndrome, the miR-574-5p expression level was 
significantly lower compared to controls (Abu-Halima, Backes, et al., 
2014), indicating that sustained lower expression of miR-574-5p 
is pivotal for the progression of infertility. MiR-638 plays a role in 
pig spermatogenesis by regulating immature Sertoli cell growth and 
apoptosis by targeting the SPAG1 gene (Hu et al., 2017). The miR-
320 family is predicted to target the protocadherin alpha proteins 
that are expressed in the mammalian testes. Protocadherin proteins 
play a crucial function in maintaining germ cells adhesion to Sertoli 
cells in the interstitial compartment of the testes (Dai et al., 2011; 
Marcon, Babak, Chua, Hughes, & Moens, 2008).
The results demonstrate higher samples correlation and thus 
homogeneity of miRNA pattern within the spermatozoa and semi-
nal plasma groups as compared to testicular tissue group. The ob-
served heterogeneity within the latter group could be explained 
by the fact that testis contains various cell types, and its compo-
sition may vary between the samples. Quantile rank analysis iden-
tifies miRNAs whose expression changes significantly relative to 
the other observed miRNAs. These analyses identified 18 miRNAs 
with significant rank changes of the mean expression values. Five of 
these miRNAs namely miR-143, miR-200c, miR-510, miR-3651 and 
miR-214 were shared between spermatozoa/testicular tissue and 
seminal plasma/testicular tissue. This may indicate a higher similar-
ity between spermatozoa and seminal plasma as compared to the 
testicular tissue. That is also supported by the fact that from the 
most expressed miRNAs for spermatozoa and seminal plasma, seven 
miRNAs namely miR-4281, miR-2861, miR-638, miR-1225-5p, miR-
320c, miR-1207-5p and miR-1202 were shared, while for testicular 
tissue three miRNAs miR-4281, miR-2861 and miR-638 were shared 
among all groups (Table 2). The expression patterns of most miRNAs 
in testicular tissue samples have also be identified as abundant in 
testis as reviewed in Kotaja (2014).
The correlation analysis was performed to see whether specific 
miRNAs are commonly regulated. As for miRNAs clustered in the 
same genomic region, a correlation of expression might indicate a 
common promoter sequence orchestrating the expression of miR-
NAs. Correlated miRNAs located on different chromosomes are 
potentially regulated by the same transcription factors (TFs) as 
reviewed extensively by Chen and Rajewsky (2007). However, it 
remains to be elucidated which TFs regulate miRNA genes in sper-
matogenesis. Identification of co-expressed miRNAs in spermato-
zoa, seminal plasma and testicular tissue is an important first step 
towards the identification of potential miRNA-regulating TFs.
Gene Ontology (GO) analysis revealed many genes involved in 
reproduction, development and differentiation. Specifically, in sper-
matozoa and testicular tissue, many of the enriched GO terms were 
directly or indirectly associated with spermatogenesis, sperm motil-
ity and flagellum, male germ cell, gamete generation and fertilisation. 
As for the seminal plasma, most of the enriched terms were directly 
or indirectly associated with regulation of protein secretion, focal 
adhesion, peptidase activity, cytoplasmic membrane-bounded ves-
icle, positive regulation of male gonad development and Sertoli cell 
differentiation.
5  | CONCLUSION
Our results suggest that there is a certain similarity between sperma-
tozoa and seminal plasma for the relative miRNA expression changes 
with respect to testicular tissue. Taken together, several miRNAs of 
unknown function were identified or demonstrated different levels 
in each sample type, suggesting that aberration of these miRNAs 
may adversely affect the rate of spermatogenesis.
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